0001209191-16-148159.txt : 20161103 0001209191-16-148159.hdr.sgml : 20161103 20161103161222 ACCESSION NUMBER: 0001209191-16-148159 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161103 FILED AS OF DATE: 20161103 DATE AS OF CHANGE: 20161103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HARVARD BIOSCIENCE INC CENTRAL INDEX KEY: 0001123494 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043306140 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 84 OCTOBER HILL RD CITY: HOLLISTON STATE: MA ZIP: 01746 BUSINESS PHONE: 5088938999 MAIL ADDRESS: STREET 1: 84 OCTOBER HILL ROAD CITY: HOLLISTON STATE: MA ZIP: 01746 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Duchemin Jeffrey CENTRAL INDEX KEY: 0001585223 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33957 FILM NUMBER: 161971719 MAIL ADDRESS: STREET 1: 14 EASTLAND TERRACE CITY: HAVERHILL STATE: MA ZIP: 01830 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-11-03 0 0001123494 HARVARD BIOSCIENCE INC HBIO 0001585223 Duchemin Jeffrey HARVARD BIOSCIENCE, INC. 84 OCTOBER HILL ROAD HOLLISTON MA 01746 1 1 0 0 Chief Executive Officer Common Stock 2016-11-03 4 P 0 15000 2.42 A 462623 D This transaction was executed in several trades between $2.35 and $2.50. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Includes (a) a deferred stock award of 291,667 restricted stock units which shall vest in four equal installments on January 1, 2017, 2018, 2019 and 2020; (b) a deferred stock award of 51,675 restricted stock units which shall vest in three equal installments on January 1, 2017, 2018 and 2019; (c) a deferred stock award of 71,748 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (c) 47,533 shares of common stock held by the Reporting Person. This form has been signed under power of attorney. /s/ Chad Porter, by power of attorney 2016-11-03